Taro Financial Statements
Taro Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Taro Income Statement
| 2005 | 2004 | 2003 | |
|---|---|---|---|
| Revenue ($ mil.) | 297.7 | 284.1 | 315.5 |
| Gross Profit ($ mil.) | 169.0 | 164.7 | 213.0 |
| Operating Income ($ mil.) | 15.2 | (0.5) | 74.7 |
| Total Net Income ($ mil.) | 5.7 | 11.1 | 61.2 |
| Diluted EPS (Net Income) | 0.19 | 0.37 | 2.06 |
Taro Stock Quote & Chart
10/10/08 16:21:17 EST •
Nasdaq Other OTC •
9.65
•
 +0.1500
•
+1.5789 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Taro Competitive Intelligence
| Novartis | Sandoz International GmbH | Teva Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 38,947.0 | 3,045.0 | 9,408.0 |
| Employees | 98,200 | 13,397 | -- |
| Market Cap ($ mil.) | -- | -- | -- |
